Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer

NCT00233402 is registered in ClinicalTrials.gov with Photocure as lead sponsor.

NCT NCT00233402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00233402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer
Lead sponsor
Photocure
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
August 31, 2008
Enrollment
789 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer